Navigation Links
Cem-Ostetic Optimal Bone Generation

ProductsCem-Ostetic Optimal Bone Generation
Company Berkeley Advanced Biomaterials
Item Cem-Ostetic Optimal Bone Generation
Features 
  • Cem-Ostetic bone void filler is indicated only for bony voids or gaps that are not intrinsic to the stability of the bone structure.
  • The putty can be molded to specific shapes and placed into the bony void or gap (e.g., extremities, spine, pelvis, or cranium), or directly injected into it.
  • When mixed with the indicated amount of sterile distilled water, the putty hardens within 5 minutes.
  • This putty is biodegradable, biocompatible, and has a neutral pH, which provides ideal conditions for healing surrounding tissues.
  • Once mixed with water for 60 seconds, the Cem-Ostetic putty can be placed in contact with other fluids, bone chips, or demineralized bone matrix to enhance bone reconstruction.
  • The Cem-Ostetic paste set in situ or ex situ provides an open void filler that can augment hardware to help support bone fragments during the surgical procedure.
  • The set putty acts as a temporary support medium and is not intended to provide structural support during the healing process. Cem-Ostetic is provided sterile for single use only.
  • Description Cem-Ostetic is a neutral pH bone putty that contains calcium-based biocompatible calcium salts that have been used for decades in orthopedic surgery. These materials are often used to provide an additional source of bone to help the patient heal faster. BAB formulates the chemistry and microstructure to enhance bone regeneration, provide optimal osteo-conduction and reduce the time for the bone to regain its full health. Cem-Ostetic's unique putty formula sets up quickly with marginal exothermic reaction (less than 4C). The putty hardens within 5 minutes. Cem-Ostetic putty is available doses ranging from 5cc to 30cc.

    Cem-Ostetic is very easy to prepare in the surgery room, as illustrated to the right. Mix the powder in the vial with the premeasured volume of sterile distilled water for 1 minute, shape your implant or inject it into the void to be filled, and let the putty harden for another 4 minutes. It's that simple!

    The formulation of Cem-Ostetic combines well-established biocompatible calcium-based phases with water and does not involve other materials such as polymers or plasticizing agents. The bone putty can be used safely to reconstruct the skeletal system. Caution: Cem-Ostetic does not harden when mixed with blood. Cem-Ostetic hardens when mixed with water first and then mixed with blood. After mixing with water, it will harden when injected into blood.
    Info Berkeley Advanced Biomaterials
    Customer Service: (510) 883-0500
    Web site: http://www.ostetic.com/

    Related medicine products :

    1. Generation II Shoulder Abduction System
    2. Innotrac Aio! 2nd Generation Troponin I Assay
    3. 3rd Generation Estradiol RIA Test
    4. 3rd Generation Estradiol EIA
    5. PSA, Third Generation
    6. Third-Generation TSH
    7. Thyroid Stimulating Hormone 3rd Generation
    8. TSH 3rd Generation
    ... Our breadth of infectious disease ELISA products ... With standard assay protocols for faster integration ... ELISA products provide increased reliability and run-to-run ... antibody detection assays for a wide range ...
    ... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
    ... breadth of infectious disease ELISA products make ... standard assay protocols for faster integration into ... products provide increased reliability and run-to-run consistency. ... detection assays for a wide range of ...
    ... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
    Medicine Products:
    (Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
    (Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
    (Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
    (Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
    (Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
    Breaking Medicine News(10 mins):
    (Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
    (Date:6/23/2016)... June 23, 2016  In a startling report released today, ... residents by lacking a comprehensive, proven plan to eliminate prescription opioid ... ranking of how states are tackling the worst drug crisis in ... states – Kentucky , New Mexico ... . Of the 28 failing states, three – ...
    (Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
    Breaking Medicine Technology: